Company News

CR Capital Mgmt Awarded as a Top 30 Specialized and Sophisticated Investment Institution in China, and Four of its Portfolio Companies Featured in the China New Economy Companies List
Released:2022-08-30

Recently, China Bridge released its 2021-2022 China Industrial Investment List and China New Economy Companies List. CR Capital Management was awarded as a Top 30 Specialized and Sophisticated Investment Institution in China. Four of its portfolio companies were featured in the China New Economy Companies List.

China Bridge 2021-2022

China Industrial Investment List

The selection took into account the size of the funds under management by the investment institutions between July 1, 2021 and June 30, 2022 and their fundraising and investment capabilities. In addition, the valuation changes and refinancing ratios of invested projects, as well as investment institutions' exit performance, integrity and media perspectives, were also taken into consideration. These aspects reflect the current overall strength of Chinese investment institutions. The 2021-2022 China Industrial Investment List has unveiled outstanding investment institutions that drive China's industrial development.

China Bridge 2021-2022

China New Economy Companies List

A number of exemplary Chinese new economy companies were selected by discovering the leaders and innovators in different fields. The list covered a wide range of fields including next-generation information technology, enterprise services, integrated circuits and semiconductors, advanced manufacturing, healthcare, and new forms of consumption. The list adhered to an objective analysis perspective and an impartial media view. It focused on the depth and potential value of industrial data, and interpreted the development patterns and trends of China's new economy companies from multiple dimensions. Now, let's take a look at the outstanding new economy companies that have led the way and driven change and innovation in the industry over the past year. Let's pay tribute to them!

Slide to see the winners' posters 

YITU

Top 10 New Economy Company

for Enterprise Services in China

Shanghai Yitu Technology Co., Ltd., invested by Deep Tech Fund, focuses on innovative research in AI. YITU is dedicated to comprehensively solving fundamental problems in how machines see, hear, understand, and plan. It provides high-performance, high-density, and universal computing power for the development, application, and popularization of AI. It also strives to meet the growing demand for intelligent computing in cloud data centers, edge computing, and the IoT. YITU uses advanced AI technology to empower industry applications for a safer, healthier and more convenient world.

UNICMICRO

Top 10 New Economy Company with the Most Growth Potential

for ICs and Semiconductors in China

Unicmicro (Guangzhou) Co., Ltd., invested by CR Microelectronics Fund, focuses on the R&D, design, and sales of low-power IoT chips. UNICMICRO provides its customers with low-power, distinctive 8-bit/32-bit microcontroller chips, wireless RF transceiver chips, digital power management chips, and sensing and signal conditioning chips for personal, home, industrial, and commercial IoT applications.

DEER

Top 10 New Economy Company

for Advanced Manufacturing in China

Fujian Deer Technology Co., Ltd., invested by CR Microelectronics Fund, is dedicated to optimizing the layout of its entire fluorine chemical industry chain. DEER is specialized in the R&D, production, and sales of basic chemical materials, fluorinated electronic gases, high-purity reagents for semiconductors, new energy materials, and other fluorinated new materials. Its products are widely used in semiconductor chips, LED chips, flat panel displays, optical fibers for telecommunications, power and energy storage batteries, ultra-high voltage transmission and transformation, and photovoltaic power generation.

AXBIO

Top 10 New Economy Company with the Most Growth Potential

for Healthcare in China

Axbio Biotechnology (Shenzhen) Co., Ltd., invested by CR Venture Capital Fund, is an innovative biotechnology company. AXBIO specializes in precision medicine and healthcare. It develops upstream core technologies, manufactures next-generation high-end devices for gene sequencing and diagnostics, and provides complete industrial solutions. AXBIO vigorously promotes the transformation of gene sequencing and molecular diagnostics from scientific research to industry and from laboratory to clinical applications by utilizing cutting-edge technologies such as nanopore sequencing, microfluidic Bio-CMOS chips, and electrochemistry.

专精特新top 30  2.png